213 related articles for article (PubMed ID: 27701383)
1. Risk of hospitalisation and death due to bone fractures after breast cancer: a registry-based cohort study.
Colzani E; Clements M; Johansson AL; Liljegren A; He W; Brand J; Adolfsson J; Fornander T; Hall P; Czene K
Br J Cancer; 2016 Nov; 115(11):1400-1407. PubMed ID: 27701383
[TBL] [Abstract][Full Text] [Related]
2. Fracture Risk in Women with Breast Cancer Initiating Aromatase Inhibitor Therapy: A Registry-Based Cohort Study.
Leslie WD; Morin SN; Lix LM; Niraula S; McCloskey EV; Johansson H; Harvey NC; Kanis JA
Oncologist; 2019 Nov; 24(11):1432-1438. PubMed ID: 31292269
[TBL] [Abstract][Full Text] [Related]
3. Fractures in a nationwide population-based cohort of users of breast cancer hormonal therapy.
Neuner JM; Shi Y; Kong AL; Kamaraju S; Smith EC; Smallwood AJ; Laud PW; Charlson JA
J Cancer Surviv; 2018 Apr; 12(2):268-275. PubMed ID: 29243101
[TBL] [Abstract][Full Text] [Related]
4. Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.
Folkestad L
Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619932
[TBL] [Abstract][Full Text] [Related]
5. Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival.
Kannegaard PN; van der Mark S; Eiken P; Abrahamsen B
Age Ageing; 2010 Mar; 39(2):203-9. PubMed ID: 20075035
[TBL] [Abstract][Full Text] [Related]
6. Hip fractures in women with breast cancer.
Adami HO; Zack M; Kressner U; Persson I; Berglund A; Naessén T; Bergkvist L
Am J Epidemiol; 1990 Nov; 132(5):877-83. PubMed ID: 2239902
[TBL] [Abstract][Full Text] [Related]
7. Fracture in asian women with breast cancer occurs at younger age.
Tsai CH; Muo CH; Tzeng HE; Tang CH; Hsu HC; Sung FC
PLoS One; 2013; 8(9):e75109. PubMed ID: 24069386
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer diagnosis and mortality by tumor stage and migration background in a nationwide cohort study in Sweden.
Abdoli G; Bottai M; Sandelin K; Moradi T
Breast; 2017 Feb; 31():57-65. PubMed ID: 27810701
[TBL] [Abstract][Full Text] [Related]
9. Fracture risk increases after diagnosis of breast or other cancers in postmenopausal women: results from the Women's Health Initiative.
Chen Z; Maricic M; Aragaki AK; Mouton C; Arendell L; Lopez AM; Bassford T; Chlebowski RT
Osteoporos Int; 2009 Apr; 20(4):527-36. PubMed ID: 18766294
[TBL] [Abstract][Full Text] [Related]
10. Fracture incidence in pre- and postmenopausal women after completion of adjuvant hormonal therapy for breast cancer.
Koopal C; Janssen-Heijnen ML; van de Wouw AJ; van den Bergh JP
Breast; 2015 Apr; 24(2):153-8. PubMed ID: 25618224
[TBL] [Abstract][Full Text] [Related]
11. The impact of treatment compliance on fracture risk in women with breast cancer treated with aromatase inhibitors in the United Kingdom.
Schmidt N; Jacob L; Coleman R; Kostev K; Hadji P
Breast Cancer Res Treat; 2016 Jan; 155(1):151-7. PubMed ID: 26687384
[TBL] [Abstract][Full Text] [Related]
12. Fracture risk in older, long-term survivors of early-stage breast cancer.
Pawloski PA; Geiger AM; Haque R; Kamineni A; Fouayzi H; Ogarek J; Petersen HV; Bosco JLF; Thwin SS; Silliman RA; Field TS
J Am Geriatr Soc; 2013 Jun; 61(6):888-895. PubMed ID: 23647433
[TBL] [Abstract][Full Text] [Related]
13. Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patients.
Ligibel JA; James O'Malley A; Fisher M; Daniel GW; Winer EP; Keating NL
Breast Cancer Res Treat; 2012 Jan; 131(2):589-97. PubMed ID: 21881937
[TBL] [Abstract][Full Text] [Related]
14. Effect of tamoxifen and aromatase inhibitors on the risk of fractures in women with breast cancer.
Vestergaard P; Rejnmark L; Mosekilde L
Calcif Tissue Int; 2008 May; 82(5):334-40. PubMed ID: 18463912
[TBL] [Abstract][Full Text] [Related]
15. Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients.
Neuner JM; Yen TW; Sparapani RA; Laud PW; Nattinger AB
Osteoporos Int; 2011 Nov; 22(11):2847-55. PubMed ID: 21170643
[TBL] [Abstract][Full Text] [Related]
16. Increased Fracture Risk in Women Treated With Aromatase Inhibitors Versus Tamoxifen: Beneficial Effect of Bisphosphonates.
Pineda-Moncusí M; Garcia-Giralt N; Diez-Perez A; Servitja S; Tusquets I; Prieto-Alhambra D; Nogués X
J Bone Miner Res; 2020 Feb; 35(2):291-297. PubMed ID: 31596961
[TBL] [Abstract][Full Text] [Related]
17. Fractures and Subsequent Graft Loss and Mortality among Older Kidney Transplant Recipients.
Salter ML; Liu X; Bae S; Chu NM; Miller Dunham A; Humbyrd C; Segev DL; McAdams-DeMarco MA
J Am Geriatr Soc; 2019 Aug; 67(8):1680-1688. PubMed ID: 31059126
[TBL] [Abstract][Full Text] [Related]
18. Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study.
Chen Z; Maricic M; Bassford TL; Pettinger M; Ritenbaugh C; Lopez AM; Barad DH; Gass M; Leboff MS
Arch Intern Med; 2005 Mar; 165(5):552-8. PubMed ID: 15767532
[TBL] [Abstract][Full Text] [Related]
19. Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study.
Hasserius R; Karlsson MK; Nilsson BE; Redlund-Johnell I; Johnell O;
Osteoporos Int; 2003 Jan; 14(1):61-8. PubMed ID: 12577186
[TBL] [Abstract][Full Text] [Related]
20. Impact of hip fracture on mortality: a cohort study in hip fracture discordant identical twins.
Michaëlsson K; Nordström P; Nordström A; Garmo H; Byberg L; Pedersen NL; Melhus H
J Bone Miner Res; 2014 Feb; 29(2):424-31. PubMed ID: 23821464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
